HPβ-CD as affordable antiviral to treat coronavirus infection
In a recent study posted to the bioRxiv* preprint server, researchers identified β-cyclodextrins (β-CDs) as a safe and cost-effective drug
Tag: CD as drug
Implementation of water-soluble cyclodextrin-based polymers in biomedical applications: how far are we?
Cyclodextrin-based polymers can be prepared starting from the naturally occurring monomers following green and low-cost procedures. They can be selectively
Cyclodextrin for treating lymphedema
A recent patent application of NATIONAL UNIVERSITY OF SINGAPORE claims for the treatment of lymphedema by using empty cyclodextrin (beta-cyclodextrin
Statistics of registered participants at the CycloLab’s webinar on “Cyclodextrins as active ingredients in the 21st century”
The webinar was a great success with altogether 793 registered participants from 66 countries. The highest interest was shown by
Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?
The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as
Cyclodextrin, beyond drug vector: When the administration matters
Cyclodextrin (CD) are classicaly know to be an excellent drug carrier although applications as active drug have been studied (orphan
Cyclodextrins in Antiviral Therapeutics and Vaccines
The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics